BPTHOTCPharmaceutical PreparationsFiscal year ends December 31
BIO-PATH HOLDINGS, INC.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.80K
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Bio-Path's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Armistice Capital, Llc 10% owner | Jan 18, 2019 | Sale | −64,457 | $2.66 | $171.46K | 129,298 |
| Armistice Capital, Llc 10% owner | Jan 18, 2019 | Sale | −0 | – | – | 129,298 |
| Armistice Capital, Llc 10% owner | Jan 18, 2019 | Sale | −0 | – | – | 129,298 |
| Michael J. Garrison Director | Jul 13, 2015 | Buy | +7,343 | $1.22 | $8.96K | 160,000 |
| Michael J. Garrison Director | Jul 9, 2015 | Buy | +8,724 | $1.17 | $10.21K | 152,657 |
| Michael J. Garrison Director | Jul 8, 2015 | Buy | +21,015 | $1.20 | $25.22K | 143,933 |
| Michael J. Garrison Director | Jul 7, 2015 | Buy | +38,985 | $1.18 | $46.00K | 122,918 |
| Michael J. Garrison Director | Jul 1, 2015 | Small purchase | +600 | $1.08 | $648 | 83,933 |
| Michael J. Garrison Director | Jun 12, 2013 | Buy | +340,000 | $0.30 | $102.00K | 673,334 |
| Thomas E. Garrison Director | Dec 2, 2009 | Buy | +350,000 | $0.25 | $87.50K | 2,511,324 |
| Thomas E. Garrison Director | Oct 13, 2009 | Buy | +400,000 | $0.25 | $100.00K | 2,161,324 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.